ChronoScale Holdings Corp — Form 8-K
Filed October 2, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 88/100
What the filing says
ChronoScale signed a contract extension with an existing AI infrastructure customer and a new customer agreement. Combined with existing contracts, these deployments are projected to generate $1 billion annualized run-rate revenue by calendar Q3 2027. The company also completed the sale of its Ekso Bionics business unit to focus on its core AI infrastructure business. No specific dollar amounts for the new contracts or Ekso sale proceeds were disclosed.
Why this rating
At $15.6M market cap, a $1B revenue run-rate claim is transformational if achieved. Business refocus via divestiture plus major customer wins are trajectory-changing. Execution risk and forward-looking nature moderate upside certainty.
Price action (we called it positive)
before filing · preread $19.21 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.